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ean	 delivery	 prevents	 vertical	 transmission	 at	 the	 time	 of	 delivery.	
Therefore,	mode	and	timing	of	delivery	should	be	individualized	based	
on	obstetric	indications	and	maternal–fetal	status.2
During	 recent	weeks,	 some	case	 reports	and	clinical	 series	have	
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The	aim	of	 the	present	article	was	to	 review	the	available	 infor-
mation	with	 special	 focus	 on	mode	 of	 delivery,	 vertical/peripartum	
transmission,	 and	 immediate	neonatal	 outcome	of	 pregnant	women	
infected	with	SARS-	CoV-	2.
2  | MATERIALS AND METHODS
We	 searched	 PubMed	 (National	 Library	 of	 Medicine,	 Washington,	
DC)	and	Embase	(Elsevier)	databases	from	January	1	up	to	March	31,	










exclusion	 criteria.	The	question	was:	 “What	 is	 the	mode	of	delivery	
and	the	obstetric	and	 immediate	neonatal	outcomes	 in	SARS-	CoV-	2	
infected	pregnant	women?”	(Table	1).
For	 each	 study,	 the	 following	 information	 was	 extracted:	 first	
author's	 last	name;	year;	country;	number	of	women	who	delivered;	






The	 primary	 outcomes	 assessed	 were	 frequency	 of	 preterm	 birth	
(<37	 weeks	 of	 gestation),	 vaginal	 delivery,	 Apgar	 score	 at	 5	 min-
utes	 <7,	 and	 newborn	 infection.	 For	 each	 study	 with	 binary	 out-




Embase.	 After	 exclusion	 of	 unrelated	 abstracts	 of	 review	 papers,	
guidelines,	 and	 commentaries,	 17	 papers	 were	 selected	 for	 exten-
sive	review.	Two	studies	reported	data	only	on	maternal	outcome.7,8 
Another	 paper	 was	 published	 without	 peer	 review.9	 One	 study	














in	 six	 (9.4%)	 cases	 (95%	 CI,	 3.5–19.3).	 Indication	 for	 cesarean	 deliv-
ery	was	worsening	of	maternal	 conditions	 in	 31	women	 (48.4%;	 95%	









(<2500	 g)	was	 observed	 in	 10	 newborns	 (10/37	 [27.0%]	 for	which	
information	was	available;	95%	CI,	13.8–44.1).	In	all	cases,	5-	minute	
Apgar	score	was	greater	than	7.	One	neonatal	death	due	to	dissem-




Considering	 respiratory	disease	 in	 newborns,	 one	 case	of	 pneu-
monia,	 one	 low-	grade	 fever	 and	 haziness	 in	 both	 lung	 fields,	 one	
high-	density	nodular	 shadow	under	 the	pleura	of	 the	 right	 lung,	 six	
shortness	 of	 breath,	 and	 two	 cases	 of	 neonatal	 respiratory	 distress	
syndrome	were	reported.
Wang	et	al.16	reported	a	case	of	neonatal	COVID-	19	infection	with	
pharyngeal	 swabs	 testing	positive	by	 rRT-	PCR	 assay	36	hours	 after	
























negative	 throat	 swab	 result	 by	 RT-	PCR	 have	 also	 been	 reported.19 








Authors, year, country Type of study Aim Assessment Cases (No.)
Chen	et	al.,	2020,	China4 Retrospective	clinical	series IVT AF,	CB,	ITS,	M 9
Chen	et	al.,	2020,	China20 Retrospective	clinical	series — — 5
Dong	et	al.,	2020,	China11 Case	report IVT IGM-	IGG,	INPS,	M,	VS 1
Fan	et	al.,	2020,	China12 Case	report IVT AF,	CB,	IGG,	INPS,	M,	PT,	VS 2
Lee	et	al.,	2020,	Korea18 Case	report IVT AF,	CB,	INPS,	PT 1
Li	et	al.,	2020,	China13 Case	report IVT AF,	CB,	IB,	IOPS,	IS,	IU,	M,	PT 1
Liu	et	al.,	2020,	China14 Retrospective	clinical	series IVT Nr 10/+3a
Liu	et	al.,	2020,	China15 Retrospective	clinical	series — — 11/+4a
Wang	et	al.,	2020,	China16 Case	report IVT CB,	IOPS,	M,	PT 1
Wang	et	al.,	2020,	China6 Case	report IVT AF,	CB,	IGJ,	IS,	ITS,	PT 1
Yu	et	al.,	2020,	China17 Retrospective	clinical	series — — 7
Zeng	et	al.,	2020,	China19 Retrospective	clinical	series IVT IB,	IGM-	IGG,	ITS 6
Zhu	et	al.,	2020,	China5 Retrospective	clinical	series IVT IOPS 9b






Authors Maternal age, y Comorbidities Antiviral therapy Pneumonia Oxygen support CCU admission
Chen	et	al.4 26–40 2	GH/9 6/9 9/9 9/9 0a/9
Chen	et	al.20 25–31 2GD,	1GH/5 5c/5 5b/5 0/5 Nr
Dong	et	al.11 29 0/1 1/1 1b/1 1/1 Nr
Fan	et	al.12 29,	34 0/2 2/2 2/2 Nr Nr
Lee	et	al.18 28 0/1 0/1 1/1 0/1 0/1
Li	et	al.13 30 0/1 1/1 1b/1 Nr Nr
Liu	et	al.14 22–36 0/13 Nr 1/13 Nr 1/13
Liu	et	al.15 23–40	(mean,	SD,	
32	+−	5)
1 GD, 1VR/11 11c/11 11/11 11/11 Nr
Wang	et	al.16 34 0/1 1c/1 1b/1 Nr Nr
Wang	et	al.6 28 0/1 1/1 1/1 1/1 1/1
Yu	et	al.17 29–34	(mean	32) 2d/7 7/7 7/7 7/7 0/7
Zeng	et	al.19 Nr Nr Nr Nr Nr Nr
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IgM	 antibodies	 to	 SARS-	CoV-	2	 were	 found	 in	 three	 cases.11,19 
Caution	in	interpreting	these	findings	has	been	suggested,	including	the	
possibility	that	IgM	positivity	could	represent	a	laboratory	artifact.23
These	 findings	 suggest	 that	 transmission	 in	 utero	 is	 possible.	
However,	SARS-	CoV-	2	was	not	found	in	amniotic	fluid	or	cord	blood	
and	this	finding	is	based	on	very	few	cases.5
Data	 on	 virus	 transmission	 are	 based	 substantially	 on	women	
who	delivered	by	cesarean.	This	aspect	 is	relevant.	 In	fact,	vertical	






although	 spontaneous	 vaginal	 preterm	 birth	was	 reported	 in	 only	





















born	 infection	 during	 breastfeeding.	 Guidelines	 suggest	 allowing	







Authors Gestational age, w
Mode of delivery
Preterm birth
Cesarean for maternal 
COVID- 19 infection
Cesarean for obstetric 
indication Vaginal delivery
Chen	et	al.4 36–39 9a/9 7a/9 — 4/9
Chen	et	al.20 38–40 — 2/5 3/5 0/5
Dong	et	al.11 37 1/1 — — 0/1
Fan	et	al.12 36,	37 2/2 — — 1/2
Lee	et	al.18 37 — 1/1 0/1
Li	et	al.13 35 — 1b/1 — 1/1
Liu	et	al.14 Nr 5c/10 5d/10 — 6/10
Liu	et	al.15 Nr 9/11 1/11 1/11 Nr
Wang	et	al.16 40 1/1 — — 0/1
Wang	et	al.6 30 1/1 — — 1/1
Yu	et	al.17 37–41 7/7 — — 0/7
Zeng	et	al.19 Nr 6/6g — — Nr
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